Bharat Rasayan Ltd (BHARATRAS) — shareholding pattern, promoter holding, financials and share price
About Bharat Rasayan Ltd (BHARATRAS)
Bharat Rasayan Ltd operates in the Pesticides & Agrochemicals industry, within the Chemicals sector. It trades on the NSE as BHARATRAS and on the BSE under scrip code 590021. Its ISIN is INE838B01021.
Bharat Rasayan Ltd is engaged in manufacturing Technical Grade Pesticides and Intermediates used in the agro-chemical industry. It was incorporated in 1989. [1]
Bharat Rasayan Limited is a manufacturer of technical formulations and intermediates used in pesticides. The company's core products include Metaphenoxy Benzaldehyde, Fenvalerate, Cypermethrin, Ethyl Ester, and Isoproturon, catering to pesticide formulating units.
The company expanded its production facilities significantly, including a notable plant at Dahej, Gujarat under Siris Crop Sciences, which was later amalgamated into Bharat Rasayan.
Listed peers in Pesticides & Agrochemicals: Insecticides India Ltd, India Pesticides Ltd, Astec Lifesciences Ltd, Punjab Chemicals & Crop Protection Ltd, Meghmani Organics Ltd, Dharmaj Crop Guard Ltd.
Valuation & Returns
10 Jul 2026At ₹1,342 a share on 10 Jul 2026, Bharat Rasayan Ltd (BHARATRAS) was valued at a price-to-earnings ratio of 3.91x against an industry P/E of 22.12x and a price-to-book of 0.5x on a book value of ₹2,659.61 per share as of Mar 2025. Solomo computes return on equity of 12.9% and return on capital employed of 16.29% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 3.91x
- Industry P/E
- 22.12x
- P/B
- 0.5x
- EPS (TTM)
- ₹342.97
- Book value / share
- ₹2,659.61
- ROE
- 12.9%
- ROCE
- 16.29%
- ROA
- 10.35%
- Debt / equity
- 0.08x
- Dividend yield
- 0.11%
- EBITDA margin
- 18.06%
- 52-week range
- ₹1,202.05 – ₹3,030.25
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Bharat Rasayan Ltd (BHARATRAS) reported revenue of ₹1,242 crore, net profit of ₹146 crore and earnings per share of ₹87.67. That compares with revenue of ₹1,171 crore and net profit of ₹141 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹308 crore and net profit ₹38 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 1,301 | 1,234 | 1,044 | 1,171 | 1,242 |
| Net profit (₹ cr) | 176 | 125 | 96 | 141 | 146 |
| EPS (₹) | 106.01 | 75.07 | 57.54 | 84.89 | 87.67 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 10.22% | -0.70% | -3.40% | 12.29% |
| Profit growth | 15.62% | -4.52% | -10.95% | 47.54% |
| Stock price CAGR | 17% | -17% | -16% | -53% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 74.99% of Bharat Rasayan Ltd (BHARATRAS) (unchanged from the previous quarter). Market capitalisation was ₹570 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2010.
Largest disclosed public shareholders in Jun 2026: Ritesh Stock Broking Private Limited 4.76%, Pgim India Trustees Private Limited A/C Pgim India Midcap Fund 1.89%, Shiv Shankar Securities Pvt. Ltd. 1.79%, Investor Education And Protection Fund Authority Ministry Of Corporate Affairs 1.79%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 74.99% | - | - | - | - |
| Mar 2026 | 74.99% | - | - | - | - |
| Dec 2025 | 74.99% | - | - | - | - |
| Sep 2025 | 74.99% | - | - | - | - |
| Jun 2025 | 74.99% | - | - | - | - |
| Mar 2025 | 74.99% | - | - | - | - |
| Dec 2024 | 74.99% | - | - | - | - |
| Sep 2024 | 74.99% | - | - | - | - |